Planned and co-organized by the U.S. Food and Drug Administration
A free live conference held at FDA's White Oak Campus, Silver Spring, MD
IMPORTANT NOTICE: The speaker presentations, transcripts, and webcast recordings are now available.
View a 1 minute video overview of the conference from ECRI Institute's President and CEO Jeffrey C. Lerner, PhD.
ECRI Institute’s 18th Annual Conference, Patient-Centeredness in Policy and Practice: A conference on evidence, programs, and implications, held November 29 and 30, 2011, was planned with and co-organized by the U.S. Food and Drug Administration; in cooperation with the U.S. Agency for Healthcare Research and Quality, Health Affairs, Foundation for Informed Medical Decision-Making, Kaiser Permanente Institute for Health Policy, American Board of Internal Medicine, Milbank Memorial Fund, and the Leonard Davis Institute for Health Economics at the University of Pennsylvania.
Current health reform and many prior initiatives are moving the healthcare system towards patient-centeredness. In a series of interactive and engaging sessions, healthcare leaders discussed these and other provocative questions:
- What is patient-centeredness, actually?
- What programs are working and how do we know?
- Will patient-centeredness have staying power?
Leading policy makers such as Margaret Hamburg, MD, Commissioner, FDA; Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality; Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiologic Health, FDA; Janet Woodcock, MD, Director, Center for Drug Evaluation and Research (CDER), FDA; Joe V. Selby, MD, MPH, Executive Director, Patient Centered Outcomes Research Institute; leaders in the field of shared decision-making between patients and their caregivers; and a host of other nationally-recognized experts including policy makers, practitioners, and researchers examined the meaning, state of the evidence, progress, and implications of patient-centeredness.
|Planned and Organized by: